In Buenos Aires, the figure of Chantal “Tati” Leclercq has gained prominence in the investigation into the so-called “Propofol Case,” which began after the death of anesthesiologist Alejandro Zalazar and led to a case for the alleged diversion and misuse of hospital drugs. Leclercq is an anesthesiology resident, and her name emerged in the file following an addition to a complaint in which she provided testimony about substance use and her connection to other case protagonists. According to what Noticias Argentinas agency could find out, the young woman maintained a friendship with the deceased anesthesiologist, with whom she coincided during her residency at the Rivadavia Hospital, and admitted to having used propofol with him “on one occasion” outside the hospital setting. Additionally, she is also linked to physician Delfina “Fini” Lanusse, accused in the case for the alleged theft of medications, with whom she shared academic and work spaces at Austral University, placing her within the close circle investigated by the Justice system. However, Leclercq is not accused in the case, although her role is considered relevant as a link between different individuals involved in an investigation seeking to determine if there was a network for obtaining and using medical drugs outside the healthcare system. The case, which centers on the use of substances like propofol and fentanyl, continues to advance as responsibilities within the health system and possible irregularities in the handling of these drugs are analyzed.
